Idiopathic intracranial hypertension
Also known as: IIH, Idiopathic pseudotumour cerebri, Primary pseudotumour cerebri syndrome
Idiopathic intracranial hypertension (IIH) is characterised by elevated intracranial pressure in the absence of an identifiable causative lesion. Specialist investigation and longitudinal monitoring are mandatory to mitigate the risk of optic nerve damage and permanent visual impairment. Clinical presentation frequently includes cephalalgia, pulsatile tinnitus, transient visual obscurations, and diplopia; however, symptomatic relief does not reliably correlate with the stabilisation of intracranial pressure. Primary management is dictated by neurology and ophthalmology, incorporating pharmacological interventions and weight-management strategies where indicated. Traditional Chinese Medicine (TCM) may be utilised as an adjunctive modality for managing comorbid discomfort, sleep disturbances, or general wellbeing, provided it does not delay conventional diagnostics or treatment. The cited evidence offers no clinical demonstration that acupuncture or Chinese herbal formulas improve IIH, intracranial pressure, or visual outcomes. The stenting case report and tinnitus review evaluate specific vascular interventions rather than TCM efficacy.
Plain-English one-pager you can print or hand to a patient. Free, no sign-in needed.
Lifestyle & Diet
- •Adhere to all scheduled neurology and ophthalmology consultations, including formal visual field testing and optic nerve monitoring.
- •Follow a medically supervised, sustainable weight-management strategy if indicated by the treating team; avoid rapid-weight-loss diets.
- •Maintain consistent sleep and nutritional schedules, and choose comfortable activity within the parameters defined by the medical team.
- •Maintain a systematic record of cephalalgia and visual symptoms. Present a comprehensive list of all medications, supplements, and herbal products at every clinical review.
Cautions & Contraindications
- •Defer elective acupuncture and herbal treatment when vision changes, neurological deterioration or suspected stent complications are present; urgent medical assessment takes priority. This is a general safety precaution; the supplied case report specifically supports vigilance for post-stenting complications, not acupuncture contraindications.[]
- •After venous stenting, coordinate with the treating team before needling or herbal prescribing. Do not interrupt prescribed antiplatelet or anticoagulant medicines. Bleeding and interaction precautions are general clinical safeguards, not outcomes tested in the supplied case report.[]
- •Do not extrapolate reported tinnitus responses after endovascular treatment of selected venous sinus diverticula to acupuncture, herbs, IIH pressure control or protection of vision; the supplied review is predominantly small observational reports.[]
When to reassess or seek care again
If medically stable and cleared for adjunctive care, review after 2–4 weeks using headache days per fortnight, a 0–10 discomfort score, sleep disruption, nausea frequency and functional interference. Check adverse effects and medication changes at every visit. Continue the specialist's visual-field and optic-nerve monitoring schedule; symptom scores cannot confirm pressure control. Stop ineffective adjunctive treatment and reassess the plan if no meaningful benefit occurs within this interval. New visual or neurological symptoms require immediate escalation, not a scheduled review.
Explore more diseases
Sources & Further Reading
Clinical guidance, red flags and safety notes on this page draw on the following current sources alongside the classical references above.
- BMC neurology · 2025
- Frontiers in surgery · 2026
- Journal of neurointerventional surgery · 2025
- Frontiers in neurology · 2025
Educational reference for licensed practitioners. Not a substitute for individual clinical assessment. Refer to conventional care for any red-flag or undiagnosed presentation.
